Tag: CDSCO
Johnson & Johnson to acquire Firefly Bio to advance novel cancer treatment
Johnson & Johnson announced that it has entered into a definitive agreement to acquire Firefly Bio, Inc., a privately held biotechnology company specializing in...
India Targets 100 New Biologic Medicines by 2047 Under Biopharma SHAKTI
At the landmark 2nd Pharma Summit & Awards 2026 organized by the Associated Chambers of Commerce and Industry of India (ASSOCHAM), the Government of...
Investors Show Strong Interest in Hexagon Nutrition IPO, Bids Reach 54 Times
Hexagon Nutrition Limited, a leading research-driven nutrition company, concluded its Initial Public Offering (IPO) with resounding success, achieving an overall subscription of 53.68 times...
AstraZeneca Advances Oral GLP-1 Elecoglipron to Phase III Programme
AstraZeneca announced positive results from the VISTA and SOLSTICE Phase IIb trials of elecoglipron, an investigational oral small molecule glucagon-like peptide-1 receptor agonist (GLP-1 RA). The data,...
ICMR Study Focuses on Vitamin Intake and Diet Diversity
A groundbreaking community-based study conducted by the ICMR-National Institute of Nutrition (ICMR-NIN) has established a significant connection between poor micronutrient status and a higher...
GSK expands deal worth $ 10.6B for lung cancer treatment
GSK plc and Nuvalent, Inc. announced that they have entered into a definitive agreement under which GSK will acquire Nuvalent, a clinical-stage biopharmaceutical company focused on...